Screener
Opko Health OPK Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 40.8%+8.1pp | 36%+4.2pp | 33.9%+3.3pp | 35.3%+5.3pp | 32.7%-2.6pp | |
| Operating margin | -8.2%+26.0pp | -17.4%+15.8pp | -19.3%+13.4pp | -17.5%— | -34.3%— | |
| Net margin | -12.4%+14.3pp | -36.6%-31.0pp | -37.2%-29.7pp | -28.1%-9.3pp | -26.7%+7.3pp | |
| Returns | ||||||
| Return on equity | -5.9%+7.3pp | -16.9%-13.9pp | -17.1%-13.3pp | -13.3%-3.9pp | -13.2%+3.4pp | |
| Return on invested capital | -3.7%+12.7pp | -7.7%+9.8pp | -7.6%+9.1pp | -7.9%— | -16.4%— | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.3×-0.1× | 3.6×+1.1× | 4×+0.5× | 3.7×+0.7× | 3.4×+1.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0.3×+0.3× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | 1.2×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $1.57-4.7% | $1.59-18.7% | $1.69-14.2% | $1.67+19.1% | $1.65-17.8% | |
| Valuation | ||||||
| Market capitalization | $985.15M-2.3% | $865.34M-22.4% | $967.3M-2.2% | $1.23B+18.4% | $1.02B+15.8% | |
| Price / sales | 1.7×+0.2× | 1.5×-0.1× | 1.6×+0.2× | 1.9×+0.5× | 1.5×+0.3× | |
| Price / book | 0.8×+0.1× | 0.7×-0.1× | 0.8×0.0× | 0.9×+0.2× | 0.8×+0.2× | |
| EV / EBITDA | 25×— | —— | —— | —— | —— |
FAQ
- What are Opko Health's profit margins?
- Opko Health (OPK) runs a 40.8% gross margin and a -8.2% operating margin, with a -12.4% net margin.
- Where do Opko Health's ratios come from?
- Every ratio is computed from Opko Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
